| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2123820 | European Journal of Cancer | 2010 | 8 Pages |
Abstract
Capecitabine at a dose of 2000Â mg/m2 is active and safe as first-line treatment of patients with metastatic breast cancer.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
M. Kaufmann, N. Maass, S.D. Costa, A. SchneeweiÃ, S. Loibl, M.W. Sütterlin, I. Schrader, B. Gerber, W. Bauer, W. Wiest, O. Tomé, A. Distelrath, V. Hagen, A. Kleine-Tebbe, E. Ruckhaeberle, K. Mehta, G. von Minckwitz,